| Active Ingredient | Fenbendazole |
| Manufacturer | Weefsel Pharma |
| Packaging | 10 X 10 Tablets / Box |
| Strength | 150 Mg |
| Delivery Time | 14-16 Days |
| SKU | Weefen 150 Mg |
| Pack | Price | Qty | Add |
|---|---|---|---|
| 100 Tablets | $120.00 | ||
| 300 Tablets | $280.00 | ||
| 500 Tablets | $400.00 | ||
| 1000 Tablets | $700.00 |
Weefen 150 mg is a Fenbendazole-based antiparasitic tablet produced by Weefsel Pharma. Fenbendazole belongs to the benzimidazole class of anthelmintic compounds with several decades of established use in veterinary medicine for the treatment and control of various parasitic worm infections in animals.
Fenbendazole is widely recognized in veterinary practice for its broad-spectrum antiparasitic activity against multiple gastrointestinal parasite types, including roundworms, hookworms, whipworms, and certain tapeworm species in appropriate animal species.
Fenbendazole does not currently hold FDA approval for any human medical indication. Any consideration of use outside established veterinary applications must be discussed with and directly supervised by a licensed healthcare or veterinary professional.
Weefen 150 mg Tablets are manufactured by Weefsel Pharma, a pharmaceutical manufacturer producing Fenbendazole formulations in compliance with applicable manufacturing and quality control standards. Production is carried out in quality-controlled facilities following stringent testing and consistency standards to ensure each tablet meets specified potency and purity requirements.
Fenbendazole has a much stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin — which forms the basis of its antiparasitic selectivity in established veterinary use.
For veterinary use:
For any use under healthcare professional supervision:
There is no established FDA-approved human dosage for Fenbendazole.
In veterinary practice, dosage requirements vary according to:
For any use considered under healthcare professional supervision, the supervising provider will determine the appropriate strength, amount, frequency, and duration based on individual clinical circumstances.
Treatment duration depends on the type of parasitic infection and the assessment of the supervising veterinarian or healthcare professional.
If the next scheduled dose is approaching, skip the missed dose and continue the regular schedule. Seek guidance from the supervising veterinarian or healthcare professional if unsure.
Based on available information from established veterinary use:
Commonly noted in veterinary use:
In limited human cases reported under medical supervision:
Seek immediate professional attention if:
Regular monitoring is strongly recommended during any period of use.
Do not use Weefen 150 mg in the following situations without professional guidance:
Limited formal drug interaction data exists for Fenbendazole. Based on currently available information:
Always inform the supervising veterinarian or healthcare professional about every medicine, supplement, and product currently being used before starting Weefen Fenbendazole.
A: Weefen 150 mg is a Fenbendazole-based antiparasitic product primarily used in veterinary practice for treating roundworm, hookworm, whipworm, and certain tapeworm infections in animals. Any use outside established veterinary applications must be under direct professional supervision.
A: Weefsel Pharma produces Weefen Fenbendazole in four strengths — 150mg, 222mg, 444mg, and 500mg — to accommodate different dosing requirements as determined by a qualified veterinarian or healthcare professional.
A: No. Fenbendazole does not currently hold FDA approval for any human medical indication. It is classified primarily as a veterinary antiparasitic compound. Any human use must only be considered under the direct supervision of a qualified healthcare professional.
A: The difference lies in the amount of Fenbendazole per tablet. Higher strengths such as 444mg and 500mg provide greater doses per tablet and are used when a higher dose is required based on body weight or clinical assessment. Strength selection must always be made by a qualified professional.
A: In veterinary practice, a 3-day course is commonly referenced for many parasitic infections, though some conditions require extended or repeated cycles. Duration is always determined by the supervising veterinarian or healthcare professional based on individual assessment.
A: In veterinary use, Fenbendazole is often mixed with food to ensure full consumption. For any supervised use, follow the specific instructions provided by the supervising professional.
A: Administer or take the missed dose as soon as possible. Never double dose. Seek guidance from the supervising professional if unsure.
A: In veterinary use, mild digestive upset, temporary appetite loss, vomiting, and diarrhea have been noted. In supervised human contexts, nausea, stomach discomfort, and elevated liver enzymes have been reported. Seek immediate professional attention for any severe or unexpected reaction.
A: Store at room temperature below 25°C away from sunlight and moisture in original packaging. Keep out of reach of children and pets at all times, and do not use past the printed expiry date.
A: Weefen Fenbendazole tablets, including the 150mg, 222mg, 444mg, and 500mg strengths, are manufactured by Weefsel Pharma in quality-controlled pharmaceutical manufacturing facilities.
Medical Disclaimer: The information shown above is for educational purposes only. Please consult your doctor or a licensed healthcare professional before taking any medicine. Never start, stop, or change any treatment without professional medical advice.
Reviews
There are no reviews yet.